×
Home Current Archive Editorial Team
Contact
Original article

This is an early access version

The impact of cognitive impairments on the quality of life of patients with multiple sclerosis

By
Aida Šehanović Orcid logo ,
Aida Šehanović
Contact Aida Šehanović

Faculty of medicine, University Clinical Center Tuzla , Tuzla , Bosnia and Herzegovina

Suljo Kunić Orcid logo ,
Suljo Kunić

Faculty of medicine, University of Tuzla , Tuzla , Bosnia and Herzegovina

Anida Šehanović Orcid logo ,
Anida Šehanović

Faculti of medicine, University Clinical Center Tuzla , Tuzla , Bosnia and Herzegovina

Dževdet Smajlović Orcid logo ,
Dževdet Smajlović

University Clinical Center Tuzla , Tuzla , Bosnia and Herzegovina

Emir Tupković Orcid logo ,
Emir Tupković

University of Tuzla , Tuzla , Bosnia and Herzegovina

Omer Ć. Ibrahimagić Orcid logo
Omer Ć. Ibrahimagić

University Clinical Center Tuzla , Tuzla , Bosnia and Herzegovina

Editor: SELMA UZUNOVIĆ

Abstract

Aim:

To assess the impact of cognitive impairments on various domains of quality of life in patients with multiple sclerosis (MS).

Methods:

This prospective study included 135 MS patients and 50 healthy controls. Participants were divided into three groups: patients with MS for more than one year (n=85), newly diagnosed MS patients (n=50), and healthy individuals (n=50). Neurocognitive assessments included the Mini-Mental State Examination, Wechsler Intelligence Scale, Revised Beta Test, Raven's Coloured Progressive Matrices, Wechsler Memory Scale, Rey-Osterrieth Complex Figure Test, Verbal Fluency Test, Audio-Verbal Learning Test, and the SF-36 Quality of Life Scale.

Results:

Cognitive impairments were present in 40–60% of MS patients, with memory dysfunctions being the most prominent (30–60%). Longer disease duration was associated with poorer visuospatial, visuoconstructive, and attention-related abilities. Patients also showed reduced logical and working memory. Quality of life was significantly lower in MS groups compared to controls, with a notable correlation between cognitive impairment and decreased MMSE scores.

Conclusion:

Cognitive impairments in MS patients, particularly those affecting memory, executive functioning, and attention, significantly reduce quality of life. Cognitive testing should be considered essential in assessing disease severity and treatment planning.

 

Author Contributions

Conceptualization, A.Š., D.S., E.T. and O.Ć.I.; Data curation, A.Š. and A.Š.; Methodology, A.Š., S.K., A.Š. and D.S.; Validation, A.Š. and D.S.; Visualization, A.Š., S.K., A.Š., D.S., E.T. and O.Ć.I.; Writing – original draft, A.Š. and S.K.; Writing – review & editing, A.Š.; Formal Analysis, S.K., D.S., E.T. and O.Ć.I.; Software, S.K.; Project administration, A.Š.; Supervision, E.T. and O.Ć.I. All authors have read and agreed to the published version of the manuscript.

Citation

Conflict of Interest

Competing interests: None to declare.

Funding Statement

No specific funding was received for this study.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.